title: Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis.
authors.affiliation: Rheumatology Department, Western General Hospital.
authors.forename: David
authors.initials: D
authors.lastname: Fraser
authors.affiliation: Rheumatology Department, Western General Hospital; boyledoc@yahoo.co.uk.
authors.forename: Stephen
authors.initials: S
authors.lastname: Boyle
authors.affiliation: Rheumatology Department, Western General Hospital, Edinburgh, UK.
authors.forename: Nicole
authors.initials: N
authors.lastname: Amft
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D001004:Anus Diseases / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle; D003424:Crohn Disease / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007150:Immunohistochemistry; D000069285:Infliximab / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D000069285:Infliximab; D001379:Azathioprine